Bram De Wilde
Ghent University Hospital · 145 works · 3,994 citations · h-index 25
Top works
- Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
- Telomerase activation by genomic rearrangements in high-risk neuroblastoma
- Emergence of New ALK Mutations at Relapse of Neuroblastoma
- A mechanistic classification of clinical phenotypes in neuroblastoma
- Targeted Expression of Mutated ALK Induces Neuroblastoma in Transgenic Mice
- Shallow Whole Genome Sequencing on Circulating Cell-Free DNA Allows Reliable Noninvasive Copy-Number Profiling in Neuroblastoma Patients
- Practical Tools to Implement Massive Parallel Pyrosequencing of PCR Products in Next Generation Molecular Diagnostics
- Massively parallel sequencing for early molecular diagnosis in Leber congenital amaurosis
- Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma
- The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children: a review
- Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM
- Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II Trial
- The Critical Role of Academic Clinical Trials in Pediatric Cancer Drug Approvals: Design, Conduct, and Fit for Purpose Data for Positive Regulatory Decisions
- Minimally invasive classification of paediatric solid tumours using reduced representation bisulphite sequencing of cell-free DNA: a proof-of-principle study
- Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium
- Target enrichment using parallel nanoliter quantitative PCR amplification
- Complex genetics of radial ray deficiencies: screening of a cohort of 54 patients
- Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial
- Severe anaphylactic reaction following anti-thymocyte globulin administration in a pediatric stem cell transplantation patient
- RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition